The Leuprolide Acetate Market is on a trajectory of robust expansion, projected to achieve a market size of $4.73 billion by 2035. This represents a remarkable compound annual growth rate (CAGR) of 6.48%. The increasing prevalence of hormone-related disorders, especially prostate cancer, is a central driver of this market growth. In North America, the rising demand for effective hormonal...